Massive safety check for Fast-Acting agitation inhaler
Symptom relief
Terminated
This study aims to monitor the safety of an already-approved inhaled medication called ADASUVE, which is used to quickly calm severe agitation in adults with schizophrenia or bipolar disorder. It will observe up to 10,000 patients in real-world hospital and emergency settings to …
Sponsor: Alexza Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Apr 02, 2026 07:26 UTC